122 related articles for article (PubMed ID: 24943689)
1. Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status.
Dovjak P; Dorfer S; Föger-Samwald U; Kudlacek S; Marculescu R; Pietschmann P
Gerontology; 2014; 60(6):493-501. PubMed ID: 24943689
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.
Wanby P; Nobin R; Von SP; Brudin L; Carlsson M
J Endocrinol Invest; 2016 Aug; 39(8):855-63. PubMed ID: 26850415
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of Dickkopf-1 are a potential negative biomarker of survival in geriatric patients.
Dovjak P; Heinze G; Rainer A; Sipos W; Pietschmann P
Exp Gerontol; 2017 Oct; 96():104-109. PubMed ID: 28652180
[TBL] [Abstract][Full Text] [Related]
4. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.
Rossini M; Viapiana O; Zanotti R; Tripi G; Perbellini O; Idolazzi L; Bonifacio M; Adami S; Gatti D
Calcif Tissue Int; 2015 May; 96(5):410-6. PubMed ID: 25694360
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
[TBL] [Abstract][Full Text] [Related]
6. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.
Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108
[TBL] [Abstract][Full Text] [Related]
7. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
[TBL] [Abstract][Full Text] [Related]
8. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
9. High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke.
He XW; Wang E; Bao YY; Wang F; Zhu M; Hu XF; Jin XP
Atherosclerosis; 2016 Oct; 253():22-28. PubMed ID: 27573735
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin levels and changes in bone metabolism after bariatric surgery.
Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
[TBL] [Abstract][Full Text] [Related]
11. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
[TBL] [Abstract][Full Text] [Related]
12. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
[TBL] [Abstract][Full Text] [Related]
13. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
[TBL] [Abstract][Full Text] [Related]
14. Circulating Myostatin Levels Decrease Transiently after Implantation of a Hip Hemi-Arthroplasty.
Kerschan-Schindl K; Tiefenböck TM; Föger-Samwald U; Payr S; Frenzel S; Marculescu R; Gleiss A; Sarahrudi K; Pietschmann P
Gerontology; 2020; 66(4):393-400. PubMed ID: 32454508
[TBL] [Abstract][Full Text] [Related]
15. Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.
Lim Y; Kim CH; Lee SY; Kim H; Ahn SH; Lee SH; Koh JM; Rhee Y; Baek KH; Min YK; Kim DY; Kim BJ; Kang MI
Calcif Tissue Int; 2016 Oct; 99(4):350-9. PubMed ID: 27289555
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin and Dkk-1 in patients with ankylosing spondylitis.
Ustun N; Tok F; Kalyoncu U; Motor S; Yuksel R; Yagiz AE; Guler H; Turhanoglu AD
Acta Reumatol Port; 2014; 39(2):146-51. PubMed ID: 25111416
[TBL] [Abstract][Full Text] [Related]
17. Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL.
Niu CC; Lin SS; Yuan LJ; Chen LH; Yang CY; Chung AN; Lu ML; Tsai TT; Lai PL; Chen WJ
BMC Musculoskelet Disord; 2017 Feb; 18(1):61. PubMed ID: 28153008
[TBL] [Abstract][Full Text] [Related]
18. Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.
Nocturne G; Pavy S; Boudaoud S; Seror R; Goupille P; Chanson P; van der Heijde D; van Gaalen F; Berenbaum F; Mariette X; Briot K; Feydy A; Claudepierre P; Dieudé P; Nithitham J; Taylor KE; Criswell LA; Dougados M; Roux C; Miceli-Richard C
PLoS One; 2015; 10(8):e0134974. PubMed ID: 26313358
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the Wnt-β-catenin signalling antagonists, sclerostin and dickkopf-related protein 1, in chronic periodontitis.
Napimoga MH; Nametala C; da Silva FL; Miranda TS; Bossonaro JP; Demasi AP; Duarte PM
J Clin Periodontol; 2014 Jun; 41(6):550-7. PubMed ID: 24576302
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]